{"title":"Real-Time Object Detector for Medical Diagnostics (RTMDet): A High-Performance Deep Learning Model for Brain Tumor Diagnosis.","authors":"Sanjar Bakhtiyorov, Sabina Umirzakova, Musabek Musaev, Akmalbek Abdusalomov, Taeg Keun Whangbo","doi":"10.3390/bioengineering12030274","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Brain tumor diagnosis requires precise and timely detection, which directly impacts treatment decisions and patient outcomes. The integration of deep learning technologies in medical diagnostics has improved the accuracy and efficiency of these processes, yet real-time processing remains a challenge due to the computational intensity of current models. This study introduces the Real-Time Object Detector for Medical Diagnostics (RTMDet), which aims to address these limitations by optimizing convolutional neural network (CNN) architectures for enhanced speed and accuracy.</p><p><strong>Methods: </strong>The RTMDet model incorporates novel depthwise convolutional blocks designed to reduce computational load while maintaining diagnostic precision. The effectiveness of the RTMDet was evaluated through extensive testing against traditional and modern CNN architectures using comprehensive medical imaging datasets, with a focus on real-time processing capabilities.</p><p><strong>Results: </strong>The RTMDet demonstrated superior performance in detecting brain tumors, achieving higher accuracy and speed compared to existing CNN models. The model's efficiency was validated through its ability to process large datasets in real time without sacrificing the accuracy required for a reliable diagnosis.</p><p><strong>Conclusions: </strong>The RTMDet represents a significant advancement in the application of deep learning technologies to medical diagnostics. By optimizing the balance between computational efficiency and diagnostic precision, the RTMDet enhances the capabilities of medical imaging, potentially improving patient outcomes through faster and more accurate brain tumor detection. This model offers a promising solution for clinical settings where rapid and precise diagnostics are critical.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 3","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11939674/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12030274","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Brain tumor diagnosis requires precise and timely detection, which directly impacts treatment decisions and patient outcomes. The integration of deep learning technologies in medical diagnostics has improved the accuracy and efficiency of these processes, yet real-time processing remains a challenge due to the computational intensity of current models. This study introduces the Real-Time Object Detector for Medical Diagnostics (RTMDet), which aims to address these limitations by optimizing convolutional neural network (CNN) architectures for enhanced speed and accuracy.
Methods: The RTMDet model incorporates novel depthwise convolutional blocks designed to reduce computational load while maintaining diagnostic precision. The effectiveness of the RTMDet was evaluated through extensive testing against traditional and modern CNN architectures using comprehensive medical imaging datasets, with a focus on real-time processing capabilities.
Results: The RTMDet demonstrated superior performance in detecting brain tumors, achieving higher accuracy and speed compared to existing CNN models. The model's efficiency was validated through its ability to process large datasets in real time without sacrificing the accuracy required for a reliable diagnosis.
Conclusions: The RTMDet represents a significant advancement in the application of deep learning technologies to medical diagnostics. By optimizing the balance between computational efficiency and diagnostic precision, the RTMDet enhances the capabilities of medical imaging, potentially improving patient outcomes through faster and more accurate brain tumor detection. This model offers a promising solution for clinical settings where rapid and precise diagnostics are critical.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering